The γ-secretase inhibitor DAPT is a potent inhibitor of the Notch signalling pathway, and therefore, it was added to the cell cultures; however, inhibition of Notch signalling did not change the expression of ADAM12 (Fig. 8C), but it inhibited the proliferation of liver cancer cells (Fig. 8D). Here, ADAM12 is linked to liver cancer.